EGFR and Pleural effusion: NCCLu-045 and 049 were derived from the pleural effusion of a patient with resistance to first-generation EGFR TKI (gefitinib) who received multiple chemotherapies; however, its growth pattern was different in suspended or adherent cultures, respectively.